Combination treatment of obesity involving 4,5-dihydro-1H-pyrazole derivatives having CB1-antagonistic activity and lipase inhibitors

Details for Australian Patent Application No. 2004283055 (hide)

Owner Solvay Pharmaceuticals GmbH

Inventors Antel, Jochen; Krause, Heinz Gunter; Wurl, Michael; Kruse, Cornelis Gerrit; Gregory, Peter-Colin; Waldeck, Harald; Lange, Josephus Hubertus Maria

Agent Watermark

Pub. Number AU-A-2004283055

PCT Pub. Number WO2005/039566

Priority 03103961.3 24.10.03 EP

Filing date 22 October 2004

Wipo publication date 6 May 2005

International Classifications

A61K 31/00 (2006.01)

A61K 31/365 (2006.01) - Lactones

A61K 31/415 (2006.01) - 1,2-Diazoles

A61K 31/4155 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/4439 (2006.01)

A61K 31/785 (2006.01)

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

Event Publications

18 May 2006 PCT application entered the National Phase

  PCT publication WO2005/039566 Priority application(s): WO2005/039566

20 May 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004283056-Novel medical uses of compounds showing CB1-antagonistic activity and combination treatment involving said compounds

2004283053-In vivo gene therapy of Parkinson's Disease